No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Qube Research
$42.2M
added
Sells/Trims (2)
Balyasny
$57.2M
trimmed
Citadel
$53.5M
trimmed
Sells (1)
Zoradi Mark
$4.4M
sold
Top-trader positions in CNK could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.02 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $1.19 / $1.02Alpha Vantage | +16.67% beat | $1.09B No estimate | Unavailable |
| Mar 31, 2026 | May 1, 2026 | -$0.06 / -$0.06Alpha Vantage | +$0.00 in line | $643.1M No estimate | Unavailable |
| Dec 31, 2025 | Feb 18, 2026 | $0.16 / $0.24Alpha Vantage | -33.33% miss | $776.3M No estimate | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $0.40 / $0.44Alpha Vantage | -9.09% miss | $857.5M No estimate | Unavailable |
| Jun 30, 2025 | Aug 1, 2025 | $0.63 / $0.75Alpha Vantage | -16.00% miss | $940.5M No estimate | Unavailable |
| Mar 31, 2025 | May 2, 2025 | -$0.35 / -$0.20Alpha Vantage | -75.00% miss | $540.7M No estimate | Unavailable |
| Dec 31, 2024 | Feb 19, 2025 | $0.33 / $0.41Alpha Vantage | -19.39% miss | $814.3M No estimate | Unavailable |
| Sep 30, 2024 | Oct 31, 2024 | $1.21 / $0.60Alpha Vantage | +101.67% beat | $921.8M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $857.5M | $776.3M | $643.1M | $1.09B |
| Cost of what it sold | $677.6M | $639.7M | $508.2M | $529.5M |
| Gross profit | $179.9M | $136.6M | $134.9M | $556.9M |
| What it spent | ||||
| Sales and admin | $61.9M | $65.6M | $56.1M | $62.4M |
| Other operating costs | — | — | $55.3M | $261.5M |
| Total operating expenses | $61.9M | $65.6M | $111.4M | $323.9M |
| What was left | ||||
| Operating profit | $118.0M | $71.0M | $23.5M | $233.0M |
| Interest on debt | $37.5M | $37.5M | $34.7M | $31.3M |
| Profit before tax | $27.6M | $42.4M | -$9.8M | $203.2M |
| Tax | -$22.9M | $7.5M | -$4.0M | $62.4M |
| Net profit | $48.9M | $34.1M | -$6.4M | $139.4M |
| EBITDA | $116.0M | $132.0M | $73.7M | $286.1M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Fifteen firms set USD 37.93 target for Cinemark Holdings stock
Leans bullishOct 17Cinemark Stock Gains 12% in a Month: Should You Buy, Hold or Sell?
BullishOct 16Cinemark Holdings stock gets USD 40.92 average analyst target
BullishOct 15Cinemark (NYSE:CNK) Hits New 12-Month High - Still a Buy?
BullishOct 15Cinemark Stock Gains 12% in a Month: Should You Buy, Hold or Sell?
BullishOct 15Cinemark stock hits 52-week high at 39.09 USD
BullishOct 15Cinemark Stock Gains 12% in a Month: Should You Buy, Hold or Sell?
BullishOct 15Cinemark (NYSE:CNK) Stock Lifted to "Strong-Buy" by Zacks Research
BullishOct 15